Abstract

Central to the pathology of malaria disease are the repeated cycles of parasite invasion and destruction of human erythrocytes. In Plasmodium falciparum, the most virulent species causing malaria, erythrocyte invasion involves several specific receptor–ligand interactions that direct the pathway used to invade the host cell, with parasites varying in their dependency on these different pathways. Gene disruption of a key invasion ligand in the 3D7 parasite strain, the P. falciparum reticulocyte binding-like homolog 2b (PfRh2b), resulted in the parasite invading via a novel pathway. Here, we show results that suggest the molecular basis for this novel pathway is not due to a molecular switch but is instead mediated by the redeployment of machinery already present in the parent parasite but masked by the dominant role of PfRh2b. This would suggest that interactions directing invasion are organized hierarchically, where silencing of dominant invasion ligands reveal underlying alternative pathways. This provides wild parasites with the ability to adapt to immune-mediated selection or polymorphism in erythrocyte receptors and has implications for the use of invasion-related molecules in candidate vaccines.

Highlights

  • Unlike many other members of the phylum Apicomplexa, malaria parasites limit their infection of host cells to the restricted population of erythrocytes in the bloodstream

  • PfRh3 Is Activated in 3D7DRh2b Parasites A number of genes that encode invasion-related proteins have been disrupted in the P. falciparum parasite strain 3D7 [8,14,33]

  • The availability of the completed P. falciparum genome has led to the identification of two families of proteins that are thought to underlie the variable receptor–ligand interactions used by malaria parasites to invade human erythrocytes

Read more

Summary

Introduction

Unlike many other members of the phylum Apicomplexa, malaria parasites limit their infection of host cells to the restricted population of erythrocytes in the bloodstream. In Plasmodium falciparum, the most virulent of malaria species infecting humans, studies with erythrocytes modified by enzyme treatment [3,4,5,6,7,8,9,10,11], or from human donors lacking surface antigens [5,6,12,13,14,15,16], have identified a number of erythrocyte receptors used by merozoites for attachment (Figure 1B) These include glycophorins A [17], B [12], and C [14] as well as unknown receptors referred to as X [12], Y [7], Z [8], and E [10]. In certain laboratory strains, such as W2mef (and its clone Dd2), the dependency on different receptors for invasion can change following either disruption of the host receptor [9] or targeted modification of the parasite ligand to which it binds [8,23]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call